Related Experiment Video
Updated: Jul 9, 2026
05:18
Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
Corticosteroid injection in diabetic patients with trigger finger. A prospective, randomized, controlled
Keith M Baumgarten1, David Gerlach, Martin I Boyer
1Sports Medicine and Shoulder Surgery Section, The Orthopedic Institute, 810 East 23rd Street, Sioux Falls, SD 57108, USA. Kbaumga@yahoo.com
The Journal of Bone and Joint Surgery. American Volume
|December 7, 2007
Summary
Corticosteroid injections are less effective for trigger finger in diabetic patients compared to non-diabetic patients. For those with diabetes, injections offered no significant improvement over placebo and did not reduce surgery rates.
Area of Science:
- Orthopedics
- Endocrinology
- Pharmacology
Background:
- Trigger finger is commonly treated with corticosteroid injections.
- The efficacy of this treatment in diabetic patients remains less understood.
Purpose of the Study:
- To evaluate corticosteroid injection efficacy for trigger finger in diabetic versus non-diabetic patients.
- To compare corticosteroid injections with placebo in diabetic patients.
Main Methods:
- Prospective, randomized, controlled, double-blinded study for diabetic patients.
- Prospective, unblinded study for non-diabetic patients.
- Thirty-five diabetic digits and twenty-nine non-diabetic digits were assessed for treatment success and need for surgery.
Main Results:
- Non-diabetic patients showed significantly higher success rates (25/29) compared to diabetic patients receiving corticosteroids (12/19) or placebo (8/15).
- Surgery rates were significantly higher in diabetic patients (corticosteroid: 7/19; placebo: 6/15) than in non-diabetic patients (3/29).
- Diabetic nephropathy and neuropathy were linked to increased need for surgery.
Conclusions:
- Corticosteroid injections are less effective for trigger finger in diabetic patients.
- In diabetic individuals, corticosteroid injections did not outperform placebo in reducing surgery rates or improving symptoms.
- Systemic diabetes complications may reduce the effectiveness of corticosteroid injections for trigger finger.
Related Concept Videos
01:31Diabetic Foot Ulcer
Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...